SCHEMBL25898677

SCHEMBL25898677

CCC(=O)c1cc(C(F)(F)F)ccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
GAA P10253 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
DDR1 Q08345 1/20 0.46
NOS3 P29474 1/20 0.44
NOS2 P35228 1/20 0.44
ADRB2 P07550 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.41
NR3C2 P08235 2/20 0.40
POLB P06746 1/20 0.40
TLR7 Q9NYK1 1/20 0.40
CHRNA7 P36544 2/20 0.39
CBLB Q13191 1/20 0.39
ANO1 Q5XXA6 2/20 0.39
RIOK2 Q9BVS4 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPT P10636 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26719914 0.85 ACHE (0.39) ALDH1A1L3MBTL1DDR1ANO1CYP2C19
SCHEMBL30989677 0.83 PTPN1 (0.50) ALDH1A1GAAL3MBTL1DDR1NOS3
SCHEMBL25887580 0.83 PTPN1 (0.50) ALDH1A1GAAL3MBTL1DDR1NOS3
SCHEMBL20956597 0.83 ALDH1A1 (0.45) ALDH1A1GAAL3MBTL1DDR1NOS3
SCHEMBL19782877 0.81 L3MBTL1 (0.56) ALDH1A1GAAL3MBTL1DDR1POLB
SCHEMBL8563867 0.81 NOS3 (0.48) ALDH1A1GAAL3MBTL1DDR1NOS3
SCHEMBL29553421 0.81 NOS3 (0.48) ALDH1A1GAAL3MBTL1DDR1NOS3
SCHEMBL20944365 0.81 GAA (0.59) ALDH1A1GAAL3MBTL1DDR1POLB
SCHEMBL29537205 0.81 GAA (0.59) ALDH1A1GAAL3MBTL1DDR1POLB
SCHEMBL29838843 0.80 NOS3 (0.52) ALDH1A1GAAL3MBTL1DDR1NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234951-A1 CYCLOPROPYL-(HETERO)ARYL-SUBSTITUTED ETHYLSULPHONYL-PYRIDINE DERIVATIVES BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234951-A1 CYCLOPROPYL-(HETERO)ARYL-SUBSTITUTED ETHYLSULPHONYL-PYRIDINE DERIVATIVES CYCS, CYP2E1, AHR ALDH1A1 637/4885GAA 2067/4885L3MBTL1 2181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.